Log In
BCIQ
Print this Print this
 

SCH 900978

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionNeurokinin 1 (NK1) receptor antagonist
Molecular Target Neurokinin 1 (NK1) substance P receptor (TACR1)
Mechanism of ActionNeurokinin-1 (NK-1) (Substance P) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCough
Indication DetailsTreat chronic cough
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today